SELECTED PUBLICATIONS
LAW REVIEW ARTICLES
Light Unseen?, 58 J. CATH. LEGAL STUDIES 5 (2020) (invited essay)
Responsible Corporate Officer Doctrine: When is Falling Down on the Job a Crime?, 6 J. Health L & Pol'y 77 (2012)
"Monitoring" Corporate Corruption: DOJ's Use of Deferred Prosecution Agreements in
Health Care, 35 Am. J.L. Med. 89 (Spring 2009) (with Simone Handler-Hutchinson)
A Civil Law Analysis: The Place of Religion in Treatment Termination Decision-Making, 15 Temp. Civ. Rts. L. Rev. 345 (2007)
Does Director Independence Improve Nonprofit Governance?, 75 Tenn. L. Rev. 83 (2007)
Mission, Margin and Trust in the Nonprofit Healthcare Enterprise, 5 Yale J. Health Pol’y, L. and Ethics 1 (2005) (T.L. Greaney)
Therapeutic Placebos: Making the Case for Patient Deception, 54 Fla. L. Rev. 687 (2002)
CAM for Kids, 1 Houston J. Health L. & Pol'y 109 (2001)
Is the Alternative Medicine? Managed Care Apparently Thinks So, 32 Conn. L. Rev. 567 (2000)
An Intimate Passing: Restoring the Role of Family and Religion in Dying, 58 U. Pitt. L. Rev. 549 (1997)
The Survival of Religious Hospitals in a World of Reformed Health Care, 31 Houston L. Rev. 1429 (1995)
Death Wish: Resuscitating Self-Determination for the Critically Ill, 35 Ariz. L. Rev. 23-85 (1993)
BOOK CHAPTERS
Entry: Organizational Ethics in the Healthcare Sector, in Bioethics, Bruce Jennings ed., 4th Edition (2014)
Legal and Ethical Issues in Complemantary and Alternative Medicine, in Complementary and Alternative Medicine: An Evidence Based Approach, Spencer & Jacobs (John Spencer & Joe Jacobs) (2003)
Problems and Conflicts Between Law and Morality in a Free Society, in Is There a Right to Life at the End of Life?, (James E. Wood & Derek Davis) (1994)
OTHER JOURNAL ARTICLES
The New Relator: In-House Counsel and Compliance Officers, 6 J. Health & Life Sciences L. 16 (2012)
Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J L Med Ethics (2012) (with Carl Coleman and Kate Greenwood)
Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)
An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)
A New Pathway to Market for Biosimilars, 4 J. H & Life Sciences L. 121 (2010) (with Judith Toffentti)
Board Independence and Transparency: Searching for the Key to Good Governance, 1 J. Health & Life Sci. L. 127 (2009)
Independence and Transparency: Keys to Good Corporate Governance, 1 J. Health & Life Sciences L. 127 (2008)
Independence and Transparency: Keys to Good Corporate Governance, 1 J. Health & Life Sciences L. 127 (2008)
National Policy on CAM: The White House Commission Report, 31 J.L. Med. & Ethics 251 (2003)
Reconciling Health Care Needs and Religious Practices, 5 Gov't L. & Pol'y J. 23 (2003)
Western Medicine Opens the Door to Alternative Medicine, XXIV J. Law & Med. 185 (1998)
Developing a Public Policy Toward the Sectarian Provider: Accommodating Religious
Beliefs and Obtaining Patient Access to Care, 24 J. Law, Medicine & Ethics 89 (1996)
CENTER PUBLICATIONS
The Role and Place of Compliance within Life Sciences: The Imperative of Chief Ethics
and Compliance Officer Independence, (2018) (with Timothy Glynn)
The Ban on Off-Label Promotion and the False Claims Act: Analyzing a Decentralized,
Public-Private Enforcement Regime, (2015) (collaborator)
Symposium: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?, Center for Religiously Affiliated Nonprofit Corporations & Center for Health & Pharmaceutical
Law (2013) (In collaboration with University of St. Thomas)
The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical
Research, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2010) (collaborator)
Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased
Oversight, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)
Drug and Device Promotion: Charting A Course for Policy Reform, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)
OTHER PUBLICATIONS
Case Study: The Abuse of Alternative Medicine?, 33 Hastings Center Rptr. 13-14 (2003)
LAW MANUALS
AHLA Pharmaceutical and Medical Device Compliance Manual, First Ed. (2012) (with Simone Handler-Hutchinson)
BOOK REVIEWS
The Aspirations and Challenges of Decision Aids, Arizona Syllabus (Spring 2013)
WORKS IN PROGRESS
In Defense of the Responsible Corporate Officer Doctrine
PRESENTATIONS
Full list of presentations available in Curriculum Vitae
Aligning the Why and How of Corporate Compliance, Middle-East Healthcare Certificate Program (Dubai: January 2023, Paris: September 2022, APAC: 2022 Zoom) (Speaker)
Aligning the Why and How of Corporate Compliance, Middle-East Healthcare Certificate Program (Dubai: January 2023, Paris: September 2022, APAC: 2022 Zoom) (Speaker)
COVID Ethics Series, Crisis Standards of Care, Hackensack Meridian Medical School/Seton Hall University (Zoom February 2022) (Speaker)
Foreign Corrupt Practices Act, Seton Hall Law School, Asia-Pacific Healthcare Compliance Certificate Program (Zoom February 2022) (Facilitator)
International Pharmaceutical Compliance, Mini Summit 1: Basic Training: Basic Elements of the Compliance Field and Profession (May 2022) (Speaker)
New Jersey State Annual Bar Meeting, Women in Charge (May 2022) (Panelist)
New Jersey State Bar Association, Health Law Section, The Life Cycle of a Medical Staff Peer Review Fair Hearing Process (March 2022) (Facilitator)
ETHICS, The Future of Compliance (Paris, November 2021) (Speaker)
COVID Ethics Series: Resource Allocation, Did Provider Boards Fall Down on the Job?, Hackensack Meridian Medical School/Seton
Hall University (November 2020) (Speaker)
J Cath Legal Studies 2020 Symposium, A Light Unseen: A History of Catholic Legal Education in the United States, St. John’s
University School of Law (February 2020) (Speaker)
Patterson Belknap RBG Podcast, Ledbetter v. Goodyear (December 2020) (Panelist)
2019 Global Compliance Congress, How Third Party Relationships Can Define Your Company’s Reputation (London: November 2019) (Moderator)
20th Annual Pharmaceutical and Medical Device Congress, Lessons Learned from Enforcement Actions, Washington D.C. (November 2019) (Panelist)
Donald S. Kent Memorial Lecture, A Comparison of the Differences between Legal and
Medical Education, New Jersey Medical Society (Fall 2017) (Co-Speaker)
Healthcare Fraud: A Crippling Problem, A Cash Cow, or a Rogue (DOJ) Agenda?, Yale Alumni Assn (Fall 2017)
Getting Students to Talk, ASLME Health Law Teachers Conference, Saint Louis University School of Law (Spring 2015) (Panelist)
The Future of the Compliance Profession, AdvaMed and Eucomed Annual Meeting, Athens, Greece (Spring 2015) (Panelist)
Off-Label Treatment: Use of Cancer Drugs Outside of Conventional Trials and Government
Approvals, The Judges and Lawyers Breast Cancer Alert and Women’s Bar Ass’n of the State of New
York, New York City Bar Ass’n (Fall 2014) (Speaker)
Annual Flora Barlotta Lecture: End of Life Care, Saint Barnabas Medical Center (Spring 2011)
U.S. Waste Fraud and Abuse Laws, E.U. Corporate Compliance Program (June 2011) (Paris, France)